Joud Hajjar, MD, MS
- Texas Medical Center
Allergy and Immunology
Clinic Chief, Adult Allergy and Immunology
Texas Children's Hospital
Assistant Professor of Medicine, Baylor College of Medicine
|Baylor College of Medicine||masters||Masters of Science in Clinical Investigations||2017|
|Virginia Commonwealth University||fellowship||Allergy and Immunology||2013|
|University of Texas MD Anderson Cancer Center||fellowship||Hospice/Palliative Care||2011|
|Indiana University School of Medicine||residency||Internal Medicine||2010|
|American University of Beirut||residency||Internal Medicine||2007|
|University of Aleppo||medical school||Doctor of Medicine||2004|
I'm trained Internal Medicine as well as Allergy and Immunology. I have launched the transition program for adolescents and young adults with primary immunodeficiency disorders at Texas Children's Hospital to transition those individuals into adult care.
My clinical interest is in primary immunodeficiency disorders, mast cells and eosinophils disorders.
My research is focused on improving Quality of life and clinical outcomes of patients with primary immunodeficiency disorders.
My philosophy is to take personal responsibility in giving our patients and families the best care that is supported by the highest order of compassion, innovation, and science. And to strive to provide our patients the highest quality of health care that will improve both their health and overall wellbeing.
Hajjar J, Habra MA, Naing A. Metformin: an old drug with new potential. Expert Opinion on Investigational Drugs 2013 Dec;22(12):1511-7. doi: 10.1517/13543784.2013.833604. Epub 2013 Aug 26. Review. PMID: 23978196 [PubMed - indexed for MEDLINE].